IRCCS OSPEDALE SAN RAFFAELE In collaboration with De Simone and Partners (IP law firm) and Fondazione Telethon, Ospedale San Raffaele is very pleased to have the opportunity to introduce to its scientific community the Patent Examiners working at the European Patent Office (EPO). The EPO, the patent granting authority for Europe, supports innovation, competitiveness and economic growth across Europe through a commitment to a high quality and efficient patent system. EPO’s examiners, each expert in a different discipline, will (i) introduce the audience into the main, basic aspects and concepts of intellectual property and patent protection, and (ii) talk about patentability requirements in three specific fields of interest (Gene Therapy, Cellbased Immunotherapy and Biologics). All with a focus on what is needed to get a valid patent in the field, the requirement of unity of invention, what minimum information is required in the priority application, and real examples and applications. The main objective of this event is to bring together science and IP law and provide best practice in patent protection. The target audience are scientists, students, post-Doc working at basic translational and clinical projects that could benefit of key and useful tips for everyday lab life. This is a unique opportunity to interact with qualified examiners and learn more about patentability requirements in science. Istituto di Ricovero e Cura a Carattere Scientifico Milan, 27 NOVEMBER 2014 Science meets European Patent Office (EPO) Aula San Paolo San Raffaele Scientific Institute, Milan PROGRAM PROGRAM MORNING SESSION Discussion 14.50 – 15.05 Welcome by Prof. Francesco Montorsi, Scientific Director and Introduction by the TTOs 9.45 – 10.00 Peptide -based Drug Delivery Systems by Dr. Angelo Corti, Director Division of Experimental Oncology 15.05 – 15.25 EPO and Patenting in Biotechnology by Dr. Maria Fotaki Content: Intellectual property basics, EPO, patenting principles, stages of filing with focus on time for filing, patenting in health sector 10.00 – 10.30 Medical Use Claims in Europe by Mr Stephen Pilling Content: Claim formats, examples, exceptions in claiming medical use of compounds and biologics 15.25 – 15.55 Discussion 10.30 – 10.45 Discussion 15.55 – 16.10 Advanced Therapy Medicinal Products by Prof. Luigi Naldini, Director San Raffaele Telethon Institute for Gene Therapy and Director Division of Regenerative Medicine, Stem Cells and Gene Therapy 10.45 – 11.05 Examination practice in the fields of Gene Therapy and Viral vectors by Dr. Laurent Deleu Content: Inventive concepts, Sufficiency of disclosure, exceptions to patentability 11.05 – 11.35 Discussion 11.35 – 11.50 12:00 - 14.00 Dr. Maria Fotaki Maria studied in Greece and completed her PhD in Molecular Biology in Canada. She worked in Hoffmann La Roche, Basel and joined EPO in 1997 as examiner in Biotechnology. Maria is director in one of the Biotechnology directorates in EPO, Munich. Dr. Andreas Gruber LUNCH and VISIT to the Labs Andreas completed his Ph.D. in natural science in Germany, and has more than 11 years of experience as patent examiner at the European Patent Office (EPO). His duties comprise the chairing of examination and opposition proceedings in the field of Biotechnology. Mr. Stephen Pilling AFTERNOON SESSION Lipid targeting Cell-based Immunotherapy by Dr. Paolo Dellabona Director Division of Immunology, Transplantation and Infectious Disease CVs of the SPEAKERS 14:00 - 14.20 Stephen studied Biochemistry at the University of North Wales and in Manchester (UK). After working for the UK National Health Service in laboratory diagnostics he joined the UK intellectual Property Office as an examiner in 1995. Following relocation to the EPO Munich in 1998 he has since been active in examination and opposition and also been involved in examiner training and quality control. Dr. Laurent Deleu Cell-based Immunotherapy, examination practice at the EPO by Dr Andreas Gruber Content: Requirements for patentability, latest developments and case law 14.20 – 14.50 Laurent studied Molecular Biology at Ecole Normale supérieure de Lyon and completed his PhD in Virology in Heidelberg. He joined the Centre national de la Recherche Scientifique (CNRS) and led a group working on oncolytic viruses at the German Cancer Research Center (DKFZ). Since 2005, he is a Patent Examiner in Biotechnology.